Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

332
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
332
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

426
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
426
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

392
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
392
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

541
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
541
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

198
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
198
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

393
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
393

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>In Vitro</i> and <i>Ex Vivo</i> evidence that pharmacological induction of the hypoxia response pathway efficiently restricts measles and Nipah virus infections.

Emerging microbes & infections·2025
Same author

Subcutaneous Infliximab for Perianal Crohn's Disease: The BioLap-Rem Multicenter Study From the GETAID.

The American journal of gastroenterology·2025
Same author

Deep Characterisation of Circulating Torque Teno Virus DNA Load in Crohn's Disease Patients.

Journal of medical virology·2025
Same author

Autophagy machinery as exploited by viruses.

Autophagy reports·2025
Same author

[Autophagy, dendritic cells, and Crohn's disease - "There is no point in running ; we must leave at the right time"].

Medecine sciences : M/S·2025
Same author

Human Endogenous Retroviruses Expression in Autoimmunity.

The Yale journal of biology and medicine·2024

Related Experiment Video

Updated: Sep 16, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.3K

Advances in Understanding Intestinal Homeostasis: Lessons from Inflammatory Bowel Disease and Monogenic Intestinal

Céline Petit1, Aurore Rozières1, Gilles Boschetti1,2

  • 1Centre International de Recherche en Infectiologie (CIRI), Université de Lyon, Université Lyon 1, Inserm U1111, CNRS UMR5308, ENS de Lyon, 69007 Lyon, France.

International Journal of Molecular Sciences
|July 12, 2025
PubMed
Summary

Inflammatory bowel diseases (IBD) and monogenic intestinal diseases (MID) involve complex gut immune and environmental interactions. This review examines IBD and MID pathophysiology to understand intestinal homeostasis mechanisms.

Keywords:
immune regulationinflammationinflammatory bowel diseaseintestinal barriermonogenic intestinal diseasevery early-onset inflammatory bowel disease

More Related Videos

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
06:57

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells

Published on: September 18, 2016

9.2K
Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
06:31

Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids

Published on: June 2, 2023

1.1K

Related Experiment Videos

Last Updated: Sep 16, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
08:40

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

7.3K
Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
06:57

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells

Published on: September 18, 2016

9.2K
Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids
06:31

Author Spotlight: Studying the Epithelial Effects of Intestinal Inflammation In Vitro on Established Murine Colonoids

Published on: June 2, 2023

1.1K

Area of Science:

  • Gastroenterology and Immunology

Background:

  • Inflammatory bowel diseases (IBD) are chronic gastrointestinal disorders with multifactorial origins.
  • Pathophysiology involves immune responses, environmental factors, and gut microbiota in genetically susceptible individuals.
  • Current therapies like anti-TNFα and anti-IL23 are effective but face resistance in some patients.

Purpose of the Study:

  • To provide a comprehensive overview of intestinal homeostasis mechanisms.
  • To examine the cellular and molecular features of IBD and MID.
  • To explore how monogenic intestinal diseases (MIDs) offer insights into intestinal health.

Main Methods:

  • Review of existing literature on IBD and MID.
  • Analysis of cellular and molecular mechanisms in disease pathophysiology.
  • Comparison of IBD and MID to understand homeostasis.

Main Results:

  • IBD pathophysiology involves complex host-immune-environment interactions.
  • MIDs result from single-gene mutations disrupting intestinal homeostasis, often with severe early-onset symptoms.
  • Studying MIDs provides a unique model for understanding intestinal homeostasis.

Conclusions:

  • Understanding IBD and MID mechanisms is crucial for advancing therapeutic strategies.
  • Further research into intestinal homeostasis can reveal novel therapeutic targets.
  • MIDs serve as valuable models for dissecting the fundamental processes of gut health.